ULBP1 and plasma cell myeloma: In addition, a significant negative correlation was found between the expression of ULBP1 ligand on myeloma cells in BM and the expression of NKG2D on blood CD56bright NK cells of ND and RR patients, which was also trending on CD56dim NK cells (Figure 3B).